Memantine HCL

About Haorui Products Technology Contact
 

 

 

 

 

 

 

 

 

Memantine HCL API

 

Haorui supplies high quality Memantine HCL API produced by our GMP facility that has been successfully inspected by the FDA. We offer competitive prices and support our products with reliable technical and regulatory services.  Memantine HCL API is available from R&D to commercial quantities. Please contact us for more details.

 

  The following information is provided for general information purposes ONLY.

 

What is Memantine HCL?

Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors.

Glutamatergic (NMDA receptor)

A dysfunction of glutamatergic neurotransmission, manifested as neuronal excitotoxicity, is hypothesized to be involved in the etiology of Alzheimer's disease. Targeting the glutamatergic system, specifically NMDA receptors, offers a novel approach to treatment in view of the limited efficacy of existing drugs targeting the cholinergic system

Memantine is a low-affinity voltage-dependent uncompetitive antagonist at glutamatergic NMDA receptors By binding to the NMDA receptor with a higher affinity than Mg2+ ions; memantine is able to inhibit the prolonged influx of Ca2+ ions which forms the basis of neuronal excitotoxicity. The low affinity and rapid off-rate kinetics of memantine at the level of the NMDA receptor-channel, however, preserves the physiological function of the receptor as it can still be activated by the relatively high concentrations of glutamate released following depolarization of the presynaptic neuron. This unique molecular mechanism of action of memantine was first discovered by the laboratory of Stuart A. Lipton, MD, PhD, then at Harvard Medical School and now at the Burnham Institute for Medical Research in La Jolla, California. The interaction of memantine with NMDA receptors plays a major role in the symptomatic improvement the drug produces in Alzheimer's disease. Moreover, there is no evidence as yet that the ability of memantine to protect against NMDA receptor-mediated excitotoxicity has a disease modifying effect in Alzheimer's, although this has been suggested in animal models.

Serotonergic (5-HT3 receptor)

Memantine acts as an uncompetitive antagonist at the 5HT3 receptor, with a potency similar to that for the NMDA receptor. The clinical significance of this serotonergic activity in the treatment of Alzheimer's disease is unknown.

Cholinergic (Nicotinic acetylcholine receptor)

Memantine acts as an uncompetitive antagonist at different neuronal nicotinic acetylcholine receptors (nAChRs) at potencies possibly similar to the NMDA and 5-HT3 receptors, but this is difficult to ascertain with accuracy because of the rapid desensitization of nAChR responses in these experiments. It has been shown that the number of nicotinic receptors in the brain are reduced in Alzheimer's disease, even in the absence of a general decrease in the number of neurons, and nicotinic receptor agonists are viewed as interesting targets for anti-Alzheimer drugs.

 

 

How does Memantine HCL work?

Memantine is used to treat the symptoms of Alzheimer's disease. Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal activity in the brain. Memantine can help people with Alzheimer's disease to think more clearly and perform daily activities more easily, but it is not a cure and does not stop the progression of the disease.

 

Who should not use Memantine HCL?

You should not use Memantine HCL if you:

bullet are allergic or sensitive to or have had a reaction to any of the ingredients in the medicine
bullet have a urinary tract infection
bullet have epilepsy or have risk factors for epilepsy
bullet have had raised blood pressure
bullet have had seizures
bullet have heart problems
bullet have kidney problems
bullet have liver problems
bullet have recently had a heart attack
bullet This medicine could affect your ability to drive or operate machinery.

 

How should I use Memantine HCL?

Memantine comes as a tablet to take by mouth. It is usually taken once or twice a day with or without food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. To help you remember to take memantine, take it at around the same time(s) every day. Take memantine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor will probably start you on a low dose of memantine and gradually increase your dose, not more than once every week.

Memantine controls Alzheimer's disease but does not cure it. Continue to take memantine even if you feel well. Do not stop taking memantine without talking to your doctor.

 

What happens if I miss a Memantine HCL dose?

Take the missed Memantine HCL dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.  

 

What happens if I overdose?

In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Symptoms of overdose may include:

bullet restlessness
bullet hallucination (seeing things or hearing voices that do not exist)
bullet sleepiness
bullet loss of consciousness

 

What should I avoid while using Memantine HCL?

This medicine could affect your ability to drive or operate machinery. It is best to avoid drinking alcohol while you are taking this medicine. Tell your doctor if you are a vegetarian or if you usually eat large amounts of citrus fruits, vegetables, beans, or peas. Your doctor will tell you if you need to change your diet. If you do not regularly eat these foods, continue your normal diet.

 

What are the possible side effects of Memantine HCL?

Memantine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

bullet extreme tiredness
bullet dizziness
bullet confusion
bullet headache
bullet sleepiness
bullet constipation
bullet vomiting
bullet pain anywhere in your body, especially your back
bullet coughing

Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:

bullet shortness of breath
bullet hallucination (seeing things or hearing voices that do not exist)

 

What other drugs will affect Memantine HCL?

The following medicines may interact with Memantine hydrochloride:

bullet amantadine
bullet baclofen
bullet cimetidine
bullet dantrolene
bullet dextromethorphan
bullet donepezil
bullet galantamine
bullet glyburide
bullet hydrochlorothiazide
bullet ketamine
bullet levodopa
bullet metformin
bullet nicotine
bullet phenytoin
bullet procainamide
bullet quinidine
bullet quinine
bullet ranitidine
bullet warfarin

The following types of medicine may interact with Memantine hydrochloride:

bullet anticholinergics
bullet antipsychotics
bullet barbiturates
bullet dopaminergics
bullet NMDA-antagonists
bullet oral anticoagulants

If you are taking Memantine hydrochloride and one of the above medicines or types of medicines, make sure your prescriber knows about it. 

 

Where can I get more information?

If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider

 

Memantine HCL Storage

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.

 

Nursing Mothers use of Memantine HCL

Women who are taking Memantine hydrochloride should not breast-feed

 

Pregnancy and use of Memantine HCL

You should only take this medicine during pregnancy if your doctor thinks that you need it.

 

Disclaimer:

 

Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.    

 

 

  Haorui - Your Partner to Pharmaceutical Success - Copy Right Reserved